Zhejiang Hisoar Pharmaceutical Co., Ltd. elected Tao Hong as non-independent director; and Yu Yongping, Qian Jianmin and Liang Chao as independent directors at the Extraordinary General Meeting held on November 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.36 CNY | +0.79% | -1.24% | -11.54% |
Apr. 28 | Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 18 | Hisoar Pharma's Unit Passes German Health Regulator's Inspection | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.54% | 1.39B | |
+30.93% | 682B | |
+30.35% | 586B | |
-3.55% | 364B | |
+18.13% | 327B | |
+4.05% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.05% | 165B |
- Stock Market
- Equities
- 002099 Stock
- News Zhejiang Hisoar Pharmaceutical Co., Ltd.
- Zhejiang Hisoar Pharmaceutical Co., Ltd. Elects Tao Hong as Non-Independent Director; and Yu Yongping, Qian Jianmin and Liang Chao as Independent Directors